JPMORGAN CHASE & CO - CUMBERLAND PHARMACEUTICALS I ownership

CUMBERLAND PHARMACEUTICALS I's ticker is CPIX and the CUSIP is 230770109. A total of 31 filers reported holding CUMBERLAND PHARMACEUTICALS I in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
JPMORGAN CHASE & CO ownership history of CUMBERLAND PHARMACEUTICALS I
ValueSharesWeighting
Q3 2023$1910
+66.7%
0.00%
Q3 2020$060.0%0.00%
Q2 2020$0
-100.0%
6
-99.8%
0.00%
Q3 2018$22,000
-64.5%
3,868
-53.8%
0.00%
Q4 2017$62,000
-34.0%
8,378
-54.6%
0.00%
Q2 2013$94,00018,4550.00%
Other shareholders
CUMBERLAND PHARMACEUTICALS I shareholders Q4 2017
NameSharesValueWeighting ↓
Stonepine Capital Management, LLC 896,170$4,615,0003.22%
Ariel Investments 1,010,220$5,203,0000.06%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 183,000$942,0000.01%
Anfield Capital Management, LLC 4,530$23,0000.01%
Financial Gravity Asset Management, Inc. 2,000$10,0000.01%
Oakworth Capital, Inc. 3,052$16,0000.00%
BAILARD, INC. 11,816$61,0000.00%
DIMENSIONAL FUND ADVISORS LP 860,319$4,431,0000.00%
Renaissance Technologies 469,338$2,417,0000.00%
ACADIAN ASSET MANAGEMENT LLC 98,192$506,0000.00%
View complete list of CUMBERLAND PHARMACEUTICALS I shareholders